Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.53 |
| ▸ | ADRB3 | P13945 | 5/20 | 0.50 |
| ▸ | PPARG | P37231 | 4/20 | 0.47 |
| ▸ | PPARA | Q07869 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4262556 | 0.84 | CYP1A2 (0.77) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL7993446 | 0.84 | CYP1A2 (0.61) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL4650970 | 0.84 | CYP1A2 (0.61) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL14533739 | 0.84 | CYP1A2 (0.61) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL7848021 | 0.83 | KMT2A (0.51) | TBXAS1EPHX2POLBSMN1; SMN2 | |
| SCHEMBL11539024 | 0.82 | CYP1A2 (0.59) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL1125165 | 0.82 | CYP1A2 (0.59) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL10207277 | 0.82 | CYP2C9 (0.59) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL1811398 | 0.82 | CYP1A2 (0.59) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL9480200 | 0.81 | L3MBTL1 (0.61) | GAATBXAS1TDP1EPHX2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050192182-A1 | Herbicidal mixtures based on substituted aryl ketones | BAYER CROPSCIENCE AG (DE) | 2005-09-01 | — | — | US | claimed |
| US-20040116294-A1 | Herbicides based on substituted aryl ketones | BAYER CROPSCIENCE AG (DE) | 2004-06-17 | — | — | US | claimed |
| JP-11269013-A | — | — | None | — | — | JP | disclosed |
| JP-H11269013-A | HERBICIDAL COMPOSITION | NISSAN CHEM IND LTD | 1999-10-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192182-A1 | Herbicidal mixtures based on substituted aryl ketones | DDT, CBR3, CYP1B1 | CYP1A2 8/4885GAA 690/4885CYP2C9 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.